Adrian Adams
2020 - IMPEL PHARMACEUTICALS
In 2020, Adrian Adams earned a total compensation of $3.7M as Chief Executive Officer and President at IMPEL PHARMACEUTICALS.
Compensation breakdown
Non-Equity Incentive Plan | $95,544 |
---|---|
Option Awards | $3,348,910 |
Salary | $266,041 |
Other | $15,330 |
Total | $3,725,825 |
Adams received $3.3M in option awards, accounting for 90% of the total pay in 2020.
Adams also received $95.5K in non-equity incentive plan, $266K in salary and $15.3K in other compensation.
Rankings
In 2020, Adrian Adams' compensation ranked 3,102nd out of 13,090 executives tracked by ExecPay. In other words, Adams earned more than 76.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,102 | 76th |
Manufacturing | 1,207 | 79th |
Chemicals And Allied Products | 460 | 80th |
Drugs | 398 | 80th |
Pharmaceutical Preparations | 297 | 80th |
Adams' colleagues
We found one more compensation record of an executive who worked with Adrian Adams at IMPEL PHARMACEUTICALS in 2020.
2020
John Leaman
IMPEL PHARMACEUTICALS